World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
51
Citations
8863
World Ranking
4154
National Ranking
1895

Michael R. Holbrook publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Michael R. Holbrook sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 144 publications — 14th percentile

14% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Michael R. Holbrook D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Michael R. Holbrook sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 51 D-Index — 17th percentile

17% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Michael R. Holbrook is affiliated with the National Institutes of Health in the United States. Their research primarily focuses on infectious diseases within the field of medicine, with an emphasis on SARS-CoV-2 and COVID-19 related studies.

The scientist's contributions to the field are reflected by publications in notable venues including bioRxiv (Cold Spring Harbor Laboratory), Antiviral Research, The Journal of Infectious Diseases, Cell Host & Microbe, and JCI Insight.

Holbrook's main areas of study cover:

  • Infectious Diseases
  • Epidemiology
  • Animal Science and Zoology
  • Molecular Biology
  • Immunology

The topics most frequently addressed in their work include:

  • SARS-CoV-2 and COVID-19 Research
  • COVID-19 Clinical Research Studies
  • Viral Infections and Outbreaks Research
  • Viral Infections and Vectors
  • Animal Virus Infections Studies
  • Viral gastroenteritis research and epidemiology
  • SARS-CoV-2 detection and testing

Some recent research papers authored or co-authored by Holbrook are:

  • Broadly neutralizing antibodies target the coronavirus fusion peptide, 2022, Science
  • Defining the risk of SARS-CoV-2 variants on immune protection, 2022, Nature
  • Bispecific antibodies targeting distinct regions of the spike protein potently neutralize SARS-CoV-2 variants of concern, 2021, Science Translational Medicine
  • Clinical, laboratory, and temporal predictors of neutralizing antibodies against SARS-CoV-2 among COVID-19 convalescent plasma donor candidates, 2020, Journal of Clinical Investigation
  • Naturally Acquired SARS-CoV-2 Immunity Persists for Up to 11 Months Following Infection, 2021, The Journal of Infectious Diseases

Frequent co-authors collaborating with Holbrook include Elena Postnikova, Janie Liang, Louis Huzella, Brett Eaton, and Yu Cong.

Best Publications

  • Repurposing of Clinically Developed Drugs for Treatment of Middle East Respiratory Syndrome Coronavirus Infection

    Julie Dyall;Christopher M. Coleman;Brit J. Hart;Thiagarajan Venkataraman

  • Antiviral Potential of ERK/MAPK and PI3K/AKT/mTOR Signaling Modulation for Middle East Respiratory Syndrome Coronavirus Infection as Identified by Temporal Kinome Analysis

    Jason Kindrachuk;Britini Ork;Brit J. Hart;Steven Mazur

  • The NS5 Protein of the Virulent West Nile Virus NY99 Strain Is a Potent Antagonist of Type I Interferon-Mediated JAK-STAT Signaling

    Maudry Laurent-Rolle;Elena F. Boer;Kirk J. Lubick;James B. Wolfinbarger

  • Defining the risk of SARS-CoV-2 variants on immune protection

    Unknown

  • Interferon-β and mycophenolic acid are potent inhibitors of Middle East respiratory syndrome coronavirus in cell-based assays.

    Brit J. Hart;Julie Dyall;Elena Postnikova;Huanying Zhou

  • Broadly neutralizing antibodies target the coronavirus fusion peptide

    Unknown

  • Possible sexual transmission of ebola virus — Liberia, 2015

    Athalia Christie;Gloria J. Davies-Wayne;Thierry Cordier-Lasalle;David J. Blackley

  • Phosphoinositide-3 Kinase-Akt Pathway Controls Cellular Entry of Ebola Virus

    Mohammad F. Saeed;Andrey A. Kolokoltsov;Alexander N. Freiberg;Michael R. Holbrook

  • Biophysical Characterization and Vector-Specific Antagonist Activity of Domain III of the Tick-Borne Flavivirus Envelope Protein

    S. Bhardwaj;M. Holbrook;R. E. Shope;Alan Barrett

  • Historical Perspectives on Flavivirus Research

    Michael R. Holbrook

  • Ubiquitin-Regulated Nuclear-Cytoplasmic Trafficking of the Nipah Virus Matrix Protein Is Important for Viral Budding

    Yao E. Wang;Arnold Park;Michael Lake;Mickey Pentecost

  • Antibody quality and protection from lethal Ebola virus challenge in nonhuman primates immunized with rabies virus based bivalent vaccine.

    Joseph E. Blaney;Andrea Marzi;Mallory Willet;Amy B. Papaneri

  • Kyasanur forest disease.

    Michael R. Holbrook

  • Three-Dimensional Organization of Rift Valley Fever Virus Revealed by Cryoelectron Tomography

    Alexander N. Freiberg;Michael B. Sherman;Marc C. Morais;Michael R. Holbrook

  • Combined chloroquine and ribavirin treatment does not prevent death in a hamster model of Nipah and Hendra virus infection.

    Alexander N. Freiberg;Melissa N. Worthy;Benhur Lee;Benhur Lee;Michael R. Holbrook

  • Solution structure and antibody binding studies of the envelope protein domain III from the New York strain of West Nile virus.

    David E. Volk;David W.C. Beasley;Deborah A. Kallick;Michael R. Holbrook

  • MERS-CoV pathogenesis and antiviral efficacy of licensed drugs in human monocyte-derived antigen-presenting cells.

    Yu Cong;Brit J. Hart;Robin Gross;Huanying Zhou

  • T-705 (Favipiravir) Inhibition of Arenavirus Replication in Cell Culture

    Michelle Mendenhall;Andrew Russell;Terry Juelich;Emily L. Messina

  • Single-particle cryo-electron microscopy of Rift Valley fever virus.

    Michael B. Sherman;Alexander N. Freiberg;Michael R. Holbrook;Stanley J. Watowich

  • Bispecific antibodies targeting distinct regions of the spike protein potently neutralize SARS-CoV-2 variants of concern.

    Hyeseon Cho;Kristina Kay Gonzales-Wartz;Deli Huang;Meng Yuan

  • Human polyclonal immunoglobulin G from transchromosomic bovines inhibits MERS-CoV in vivo.

    Thomas Luke;Hua Wu;Jincun Zhao;Jincun Zhao;Rudragouda Channappanavar

  • Antiviral activities of ISG20 in positive-strand RNA virus infections.

    Zhi Zhou;Nan Wang;Sara E. Woodson;Qingming Dong

  • Inactivated or Live-Attenuated Bivalent Vaccines That Confer Protection against Rabies and Ebola Viruses

    Joseph E. Blaney;Christoph Wirblich;Amy B. Papaneri;Reed F. Johnson

  • Inactivation and safety testing of Middle East Respiratory Syndrome Coronavirus.

    Mia Kumar;Steven Mazur;Britini L. Ork;Elena Postnikova

  • Injectable peramivir mitigates disease and promotes survival in ferrets and mice infected with the highly virulent influenza virus, A/Vietnam/1203/04 (H5N1).

    Nadezhda E. Yun;Nathaniel S. Linde;Michele A. Zacks;Ian G. Barr

  • Japanese Encephalitis Vaccines.

    Monica A McArthur;Michael R Holbrook

Frequent Co-Authors

Peter B. Jahrling
Peter B. Jahrling National Institute of Allergy and Infectious Diseases
Lisa E. Hensley
Lisa E. Hensley National Institutes of Health
Alexander N. Freiberg
Alexander N. Freiberg The University of Texas Medical Branch at Galveston
Alan D.T. Barrett
Alan D.T. Barrett The University of Texas Medical Branch at Galveston
Gene G. Olinger
Gene G. Olinger Boston University
Jens H. Kuhn
Jens H. Kuhn National Institutes of Health
David W.C. Beasley
David W.C. Beasley The University of Texas Medical Branch at Galveston
Matthew B. Frieman
Matthew B. Frieman University of Maryland, Baltimore
Robert E. Shope
Robert E. Shope The University of Texas Medical Branch at Galveston
Benhur Lee
Benhur Lee Icahn School of Medicine at Mount Sinai

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in studying Immunology in the USA, exploring related degrees can open diverse career opportunities in healthcare and research. Online programs provide flexible options, with some of the easiest np programs to get into making it more accessible for students aiming to advance their clinical skills.

If specializing in mental health appeals to you, consider top-ranked top psychiatric mental health nurse practitioner programs online. These programs not only offer comprehensive coursework but also boast excellent clinical placement rates, essential for gaining hands-on experience.

Budget-conscious students can find quality education through the cheapest online pmhnp certificate programs. Affordable programs reduce financial barriers while still preparing graduates for rewarding roles in psychiatric nursing and related fields.

Career prospects post-graduation look promising, with data showing competitive compensation. Understanding how much does a dnp make can help set realistic salary expectations and guide choices about where to live and work after earning a Doctor of Nursing Practice degree.

Best Scientists Citing Michael R. Holbrook

Trending Scientists

Recently Published Articles